Cargando…
Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease
To find a new biomarker of Tay-Sachs disease and Sandhoff disease. The lyso-GM2 ganglioside (lyso-GM2) levels in the brain and plasma in Sandhoff mice were measured by means of high performance liquid chromatography and the effect of a modified hexosaminidase (Hex) B exhibiting Hex A-like activity w...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243693/ https://www.ncbi.nlm.nih.gov/pubmed/22205997 http://dx.doi.org/10.1371/journal.pone.0029074 |
_version_ | 1782219688332230656 |
---|---|
author | Kodama, Takashi Togawa, Tadayasu Tsukimura, Takahiro Kawashima, Ikuo Matsuoka, Kazuhiko Kitakaze, Keisuke Tsuji, Daisuke Itoh, Kohji Ishida, Yo-ichi Suzuki, Minoru Suzuki, Toshihiro Sakuraba, Hitoshi |
author_facet | Kodama, Takashi Togawa, Tadayasu Tsukimura, Takahiro Kawashima, Ikuo Matsuoka, Kazuhiko Kitakaze, Keisuke Tsuji, Daisuke Itoh, Kohji Ishida, Yo-ichi Suzuki, Minoru Suzuki, Toshihiro Sakuraba, Hitoshi |
author_sort | Kodama, Takashi |
collection | PubMed |
description | To find a new biomarker of Tay-Sachs disease and Sandhoff disease. The lyso-GM2 ganglioside (lyso-GM2) levels in the brain and plasma in Sandhoff mice were measured by means of high performance liquid chromatography and the effect of a modified hexosaminidase (Hex) B exhibiting Hex A-like activity was examined. Then, the lyso-GM2 concentrations in human plasma samples were determined. The lyso-GM2 levels in the brain and plasma in Sandhoff mice were apparently increased compared with those in wild-type mice, and they decreased on intracerebroventricular administration of the modified Hex B. The lyso-GM2 levels in plasma of patients with Tay-Sachs disease and Sandhoff disease were increased, and the increase in lyso-GM2 was associated with a decrease in Hex A activity. Lyso-GM2 is expected to be a potential biomarker of Tay-Sachs disease and Sandhoff disease. |
format | Online Article Text |
id | pubmed-3243693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-32436932011-12-28 Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease Kodama, Takashi Togawa, Tadayasu Tsukimura, Takahiro Kawashima, Ikuo Matsuoka, Kazuhiko Kitakaze, Keisuke Tsuji, Daisuke Itoh, Kohji Ishida, Yo-ichi Suzuki, Minoru Suzuki, Toshihiro Sakuraba, Hitoshi PLoS One Research Article To find a new biomarker of Tay-Sachs disease and Sandhoff disease. The lyso-GM2 ganglioside (lyso-GM2) levels in the brain and plasma in Sandhoff mice were measured by means of high performance liquid chromatography and the effect of a modified hexosaminidase (Hex) B exhibiting Hex A-like activity was examined. Then, the lyso-GM2 concentrations in human plasma samples were determined. The lyso-GM2 levels in the brain and plasma in Sandhoff mice were apparently increased compared with those in wild-type mice, and they decreased on intracerebroventricular administration of the modified Hex B. The lyso-GM2 levels in plasma of patients with Tay-Sachs disease and Sandhoff disease were increased, and the increase in lyso-GM2 was associated with a decrease in Hex A activity. Lyso-GM2 is expected to be a potential biomarker of Tay-Sachs disease and Sandhoff disease. Public Library of Science 2011-12-20 /pmc/articles/PMC3243693/ /pubmed/22205997 http://dx.doi.org/10.1371/journal.pone.0029074 Text en Kodama et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Kodama, Takashi Togawa, Tadayasu Tsukimura, Takahiro Kawashima, Ikuo Matsuoka, Kazuhiko Kitakaze, Keisuke Tsuji, Daisuke Itoh, Kohji Ishida, Yo-ichi Suzuki, Minoru Suzuki, Toshihiro Sakuraba, Hitoshi Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease |
title | Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease |
title_full | Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease |
title_fullStr | Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease |
title_full_unstemmed | Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease |
title_short | Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease |
title_sort | lyso-gm2 ganglioside: a possible biomarker of tay-sachs disease and sandhoff disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243693/ https://www.ncbi.nlm.nih.gov/pubmed/22205997 http://dx.doi.org/10.1371/journal.pone.0029074 |
work_keys_str_mv | AT kodamatakashi lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease AT togawatadayasu lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease AT tsukimuratakahiro lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease AT kawashimaikuo lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease AT matsuokakazuhiko lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease AT kitakazekeisuke lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease AT tsujidaisuke lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease AT itohkohji lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease AT ishidayoichi lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease AT suzukiminoru lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease AT suzukitoshihiro lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease AT sakurabahitoshi lysogm2gangliosideapossiblebiomarkeroftaysachsdiseaseandsandhoffdisease |